Healthcare provider profile · identity verified

Albert M. Veltri, MD

Family Practice · IDA GROVE, IA · NPI 1194811307

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	855	165
Levothyroxine Sodium	Levothyroxine Sodium	552	84
Pantoprazole Sodium	Pantoprazole Sodium	399	66
Eliquis	Apixaban	378	53
Amlodipine Besylate	Amlodipine Besylate	364	66
Losartan Potassium	Losartan Potassium	298	63
Furosemide	Furosemide	296	59
Omeprazole	Omeprazole	296	55
Metoprolol Succinate	Metoprolol Succinate	292	56
Carvedilol	Carvedilol	277	43
Lisinopril	Lisinopril	273	46
Potassium Chloride	Potassium Chloride	244	39
Gabapentin	Gabapentin	200	37
Sertraline Hcl	Sertraline Hcl	191	35
Tamsulosin Hcl	Tamsulosin Hcl	189	38
Metoprolol Tartrate	Metoprolol Tartrate	187	29
Alendronate Sodium	Alendronate Sodium	182	27
Bumetanide	Bumetanide	168	29
Allopurinol	Allopurinol	162	26
Rosuvastatin Calcium	Rosuvastatin Calcium	162	28
Spironolactone	Spironolactone	153	21
Prednisone	Prednisone	151	84
Clopidogrel	Clopidogrel Bisulfate	147	23
Metformin Hcl	Metformin Hcl	145	31
Ropinirole Hcl	Ropinirole Hcl	144	17
Jantoven	Warfarin Sodium	133	13
Tramadol Hcl	Tramadol Hcl	130	41
Hydrochlorothiazide	Hydrochlorothiazide	125	20
Zolpidem Tartrate	Zolpidem Tartrate	119	24
Hydralazine Hcl	Hydralazine Hcl	117	18
Trazodone Hcl	Trazodone Hcl	115	20
Benazepril Hcl	Benazepril Hcl	100	16
Meloxicam	Meloxicam	90	16
Cephalexin	Cephalexin	88	51
Escitalopram Oxalate	Escitalopram Oxalate	87	12
Levetiracetam	Levetiracetam	87	11
Montelukast Sodium	Montelukast Sodium	85	14
Celecoxib	Celecoxib	84	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	84	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	29
Albuterol Sulfate Hfa	Albuterol Sulfate	75	23
Mirtazapine	Mirtazapine	72	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	69	suppressed
Lorazepam	Lorazepam	66	14
Oxycodone Hcl	Oxycodone Hcl	66	suppressed
Finasteride	Finasteride	65	11
Oxybutynin Chloride Er	Oxybutynin Chloride	64	15
Memantine Hcl	Memantine Hcl	63	suppressed
Glipizide	Glipizide	61	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	suppressed
Azithromycin	Azithromycin	57	39
Xarelto	Rivaroxaban	57	suppressed
Famotidine	Famotidine	56	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	56	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Chlorthalidone	Chlorthalidone	55	12
Pregabalin	Pregabalin	52	suppressed
Atenolol	Atenolol	50	suppressed
Amiodarone Hcl	Amiodarone Hcl	46	suppressed
Donepezil Hcl	Donepezil Hcl	46	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	46	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	15
Warfarin Sodium	Warfarin Sodium	44	11
Pioglitazone Hcl	Pioglitazone Hcl	41	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Calcitriol	Calcitriol	35	suppressed
Budesonide	Budesonide	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Tresiba Flextouch U-100	Insulin Degludec	31	suppressed
Novolin N	Insulin Nph Human Isophane	30	suppressed
Oxycontin	Oxycodone Hcl	30	suppressed
Ozempic	Semaglutide	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Digoxin	Digoxin	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Fentanyl	Fentanyl	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Sotalol	Sotalol Hcl	27	suppressed
Diazepam	Diazepam	26	suppressed
Metolazone	Metolazone	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Ondansetron Odt	Ondansetron	25	12
Propranolol Hcl	Propranolol Hcl	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Dutasteride	Dutasteride	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Risperidone	Risperidone	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	suppressed
Baclofen	Baclofen	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Linzess	Linaclotide	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	20	suppressed
Cefdinir	Cefdinir	19	17
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Topiramate	Topiramate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Ramipril	Ramipril	16	suppressed
Simvastatin	Simvastatin	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Temazepam	Temazepam	16	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Estradiol	Estradiol	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Levetiracetam Er	Levetiracetam	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Divalproex Sodium	Divalproex Sodium	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Cartia Xt	Diltiazem Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Torsemide	Torsemide	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error